Cure My Disease

Don't miss your cure!

 Log in / Sign up

Anxiety program for youth shows promise in new study

NCT ID NCT02305537

Knowledge-focused Sponsor: Mclean Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 559 children and teens ages 6 to 19 in the McLean Anxiety Mastery Program to see if their anxiety and depression improved with treatment. Researchers compared patients who received treatment to those on a waitlist and checked if gains lasted three months after discharge. The goal was to gather data to understand how well the program works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

559 people

The number who actually took part.

Started

Oct 2014

Finished

Nov 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 19 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All youth who are eligible to participate in the McLean Anxiety Mastery Program will be invited to participate in the research study. * Eligibility criteria for the McLean Anxiety Mastery Program include: * children and adolescents who are between the ages of 6 and 19 and * who present with at least one of the following disorders: * Separation Anxiety Disorder, * Social Anxiety Disorder, * Panic Disorder, * Agoraphobia, * Specific Phobia(s), and * OCD. * Interested and eligible patients and their caregivers should complete and submit an application (https://www.mcleanhospital.org/sites/default/files/2021-07/MAMP-Application-07032021\_0.pdf) to begin the phone screen process. Exclusion Criteria: * Patients ineligible for the treatment program, and therefore the study, include those who have engaged in substance abuse during the six weeks prior to the first evaluation (i.e., waitlist or admission) the phone screening, * those who report that they are unwilling to refrain from self-injurious behaviors during the waitlist and treatment periods, * those who are experiencing active symptoms of psychosis, * those who exhibit severe behavioral disinhibition or aggression, and * those who express an intent and/or plan to commit suicide or homicide at the time of their first evaluation the initial phone screening. * Patients must be fluent in English to participate in the program because all off-grounds exposure groups will be conducted in English (whenever possible, however, translation services will be provided for patients whose parents are not fluent in English).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Agoraphobia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agoraphobia obsessive-compulsive disorder panic disorder separation anxiety disorder social phobia specific phobia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Agoraphobia Obsessive - compulsive disorder Panic disorder Separation anxiety disorder Social anxiety disorder Specific phobia

Contacts and locations

Locations

  • McLean Hospital

    Cambridge, Massachusetts, 02138, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.